A massive U.S. study reports that adults with attention-deficit/hyperactivity disorder face over four times the hazard of later-life dementia or mild cognitive impairment.
Story Snapshot
- A 187,341-person analysis linked adult attention-deficit/hyperactivity disorder to higher later cognitive decline risk.
- About 6.7% with attention-deficit/hyperactivity disorder developed impairment, versus 3.4% without it.
- Genetic risk for attention-deficit/hyperactivity disorder also tracked with higher impairment risk.
- The research team published the findings in JAMA Psychiatry with named investigators.
What the new study actually found
University of Pittsburgh researchers analyzed 187,341 adults aged 50 and older from the National Institutes of Health All of Us program over about 10 years. Adults with an attention-deficit/hyperactivity disorder diagnosis had a hazard ratio of 4.60 for developing mild cognitive impairment or dementia, compared with adults without the diagnosis. The confidence interval ran from 3.99 to 5.29, and the finding met strong statistical thresholds. The report states these results appeared in JAMA Psychiatry with named authors leading the work.
Absolute outcomes moved in the same direction. About 6.7% of adults with attention-deficit/hyperactivity disorder developed impairment versus 3.4% without it. That gap looks smaller than the fourfold hazard ratio, which reflects model adjustments and time-to-event analysis rather than a raw proportion. Both signals still point the same way: adults with attention-deficit/hyperactivity disorder in this sample had more diagnosed impairment events during follow-up.
How the team strengthened the analysis
The group drew on both electronic health records and genetic data rather than a small clinic cohort. Researchers reported a genetic angle that supported the main result. Participants in the highest genetic risk group for attention-deficit/hyperactivity disorder had a 35% higher hazard of later cognitive impairment than those in the lowest group. That genetic signal cannot prove cause, but it adds a second line of evidence that liability to attention-deficit/hyperactivity disorder tracks with later decline risk.
The team attributed the work to named investigators and set the paper in a peer-reviewed psychiatric journal. That matters for transparency and scrutiny. Publication details identify University of Pittsburgh leadership, including Tharick Pascoal, Medical Doctor and Doctor of Philosophy, among the authors. The formal venue invites methods review and replication by independent groups.
Where this fits in the wider research
Other large studies have linked adult attention-deficit/hyperactivity disorder with higher dementia risk, though with smaller relative sizes on average. A meta-analysis pooling several cohorts estimated about a two-and-a-half times higher risk, which sits below this new fourfold hazard but in the same direction. Reviews also flag that absolute risk remains modest in population terms, even when relative risk rises, which aligns with the 6.7% versus 3.4% split here.
Prior work has also described stronger links to some non-memory dementia types, such as Lewy body disease, and has urged clear clinical sorting between lifelong attention symptoms and age-related decline. That call reflects a practical challenge in clinics: symptoms can overlap, so careful assessment and tracking matter when older adults report new attention problems.
What this means for families and clinicians
The take-home for families is simple and actionable: know your baseline, watch for changes, and manage the big, fixable risks. Adults with attention-deficit/hyperactivity disorder should keep blood pressure, sleep, diabetes, exercise, mood, and alcohol use in good shape, because those factors also drive brain aging. Clinicians can document childhood-onset attention-deficit/hyperactivity disorder versus new-onset symptoms, review medications, and schedule periodic cognitive checks when history or function shifts.
Dementia risk more than quadruples among adults with common disorder
The findings — which were published Oct. 7 in JAMA Psychiatry — only show an association and cannot determine that ADHD increases dementia risk, the researchers acknowledged.
"This doesn’t prove that ADHD…
— JV (@joveg8) October 13, 2026
One measured caveat belongs here and only once: the study design shows association, not cause. The link held after adjustments, and a genetic signal lined up the same way, but mechanisms remain open. That is not a reason to ignore the finding. It is a reason to double down on common-sense steps that protect brain health, and to refine future research that separates lifelong attention-deficit/hyperactivity disorder from emerging cognitive disease.
Sources:
foxnews.com, medscape.com, eurekalert.org, wesanews.org, wfmd.com, medpagetoday.com
